For patients with severe eosinophilic asthma, biologic therapy can reduce exacerbations and lower reliance on rescue inhalers. TwelveStone Health Partners administers Fasenra injection treatment for adults and children ages 6 and older when prescribed as part of a specialist-guided care plan.
Our PharmD-led clinical teams prepare and administer this medication in comfortable, private care suites across 30+ infusion centers in Tennessee, Kentucky, Georgia, Mississippi, and Virginia. We handle scheduling, insurance verification, and care coordination so you can focus on your treatment without administrative delays.
Clinical Outcomes and What to Expect
Fasenra (benralizumab) targets eosinophils, the white blood cells responsible for airway inflammation in this asthma subtype. By reducing eosinophil activity, it helps control the underlying cause of severe flare-ups rather than only managing symptoms after they occur.
Most patients experience fewer severe exacerbations and reduced reliance on rescue inhalers over time. Improvement develops gradually across multiple doses as the biologic stabilizes the condition, making Fasenra a long-term controller rather than a rescue treatment.
TwelveStone clinical staff track your progress using objective markers such as lung function, symptom frequency, and rescue medication use. This oversight ensures your care plan stays aligned as your condition improves. Learn how TwelveStone supports asthma patients through coordinated specialty care.
Eligibility for Fasenra Injection Treatment
Fasenra is indicated for patients aged 6 and older with severe eosinophilic asthma that remains uncontrolled despite high-dose controller inhalers. Final qualification is determined by your prescribing clinician and insurance provider.
A key indicator for this therapy is an eosinophilic phenotype confirmed by elevated blood eosinophil levels. Patients are typically considered if they meet several clinical criteria:
- Frequent asthma exacerbations despite maintenance therapy
- Repeated need for oral steroid bursts
- Persistent daily symptoms on current medications
- Lab-confirmed elevated eosinophil levels
TwelveStone clinical teams work with your provider to verify these criteria and manage the insurance authorization process. For pediatric patients, consistent therapy can support regular school attendance and daily activity participation.
The Fasenra Administration Process
Unlike many specialty medications that require intravenous infusions, Fasenra is administered as a subcutaneous injection placed just under the skin. This typically results in shorter visits compared to traditional IV treatments. TwelveStone clinical staff manage every step:
Check-in and symptom review
Staff confirm any changes to your medications or recent health status.
Prescription verification
Dosage and medication accuracy are confirmed before administration.
Injection administration
A trained nurse delivers the subcutaneous injection per your prescribing clinician’s protocol.
Post-dose observation
Staff monitor for reactions during the observation period before you leave.
Registered nurses monitor for adverse reactions throughout your visit. You receive supervised care in private care suites, providing a level of safety that self-administration at home cannot match.
Is Fasenra an Injection or an Infusion?
Fasenra is a subcutaneous injection, not an intravenous infusion. Infusions deliver medication directly into a vein through an IV line, while Fasenra is administered just under the skin. TwelveStone provides a supervised clinical setting to ensure each dose is delivered safely and accurately.
Insurance Coordination and Treatment Access
TwelveStone clinical coordinators manage communication between your prescribing physician and insurance provider from the start. Once an order is received, our team begins coordinating care to reduce administrative delays.
Insurance and Prior Authorization Support
We handle benefits verification and prior authorization requirements. Coverage varies by plan, but we help clarify expected out-of-pocket costs and identify available copay assistance programs before your first visit.
Regional Center Access
TwelveStone operates more than 30 centers across Tennessee, Kentucky, Georgia, Mississippi, and Virginia. Use our location tool to find a center near you.
Intake and Onboarding
New patients receive onboarding support and educational materials through our patient resources hub. To begin the intake process, have the following ready:
- Prescriber name and diagnosis
- Insurance provider information
- Current asthma medication history
Frequently Asked Questions About Fasenra Treatment
Get Started With Fasenra Injection Treatment
TwelveStone Health Partners provides Fasenra treatment through a network of 30+ infusion centers across the Southeast. Our clinical team manages coordination from referral to administration, simplifying access to specialty biologic therapy.
